Home » Topics » Disease categories and therapies » Cardiovascular

Cardiovascular
RSS

Ribozyme oligonucleotides against apo(a) as novel therapeutic strategy for cardiovascular diseases

Nov. 5, 1998

Merck's new ET receptor antagonists

Nov. 5, 1998

Optimal dosing regimen for 5G1.1-SC in heart attack under evaluation in phase I trial

Nov. 4, 1998

Involvement of central A3 receptors in blood pressure regulation

Nov. 3, 1998

Suntory describes new series for cardio- and cerebrovascular and peripheral circulatory disorders

Nov. 3, 1998

Cardioprotective effects of carvedilol metabolite are less potent than those of the parent drug

Nov. 3, 1998

Continuing efforts at Parke-Davis result in structurally novel functional ETA receptor antagonist

Nov. 2, 1998

New K+ channel blockers for arrhythmias, ulcers and related disorders

Nov. 2, 1998

How does bradykinin receptor blockade affect responses to ACE inhibition?

Oct. 30, 1998

UT-15 administered successfully to patients with impaired liver function

Oct. 30, 1998

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...